{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:16:47Z","timestamp":1760267807413,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/purpose<\/jats:title>\n                <jats:p>Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in the pediatric population and anterior uveitis is its commonest extra-articular manifestation. Typically the uveitis presents as chronic anterior uveitis and there is limited literature of the posterior segment manifestations of the disease. Similar to other vaccines, anti-SARS-CoV-2 vaccination that began as an urgent measure to control the spread of the SARS-CoV-2 pandemic has not been without adverse events. We are reporting a 19-year-old Asian Indian female who was diagnosed and treated for JIA associated anterior uveitis that was unilateral and was under anti-inflammatory control but showed worsening of uveitis with posterior segment inflammation in both eyes following anti-SARS-CoV-2 vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>A 19-year-old Asian Indian female with a history of juvenile idiopathic arthritis on treatment with methotrexate, presented with right eye chronic anterior uveitis with peripheral subclinical retinal vasculitis and macular edema which was brought under control following administration of adalimumab. She was inflammation free for 6\u2009months until she received anti-SARS-CoV-2 vaccination and developed new onset floaters in both eyes that were initially noted after the first dose and increased after the second dose. Clinical examination revealed presence of keratic precipitates and grade 1+ anterior chamber inflammation along with vitiritis in both eyes. Fundus fluorescein angiography revealed angiographically active retinal vasculitis without the presence of macular edema in both eyes. This was managed with a short course of topical difluprednate and continuation of systemic immunosuppressive therapy with adalimumab and methotrexate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>JIA associated uveitis results from an autoimmune process which can be controlled with timely immunosuppressive treatment. It is important to be aware of the potential risk of flare up of uveitis with posterior segment manifestations following anti- SARS-CoV-2 vaccination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-022-00294-2","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T09:03:10Z","timestamp":1651050190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-8870","authenticated-orcid":false,"given":"Padmamalini","family":"Mahendradas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Bhakti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubble","family":"Mangla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasan","family":"Sanjay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankush","family":"Kawali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balebail","family":"Dharmanand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"4","key":"294_CR1","first-page":"1","volume":"36","author":"RJ Kaur","year":"2021","unstructured":"Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S (2021) Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem. IJCB 36(4):1\u201313 Advance online publication","journal-title":"IJCB"},{"issue":"1","key":"294_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","volume":"14","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, Sen ES, Ramanan AV (2016) Juvenile idiopathic arthritis-associated uveitis. Pediatric Rheumatol Online J 14(1):27","journal-title":"Pediatric Rheumatol Online J"},{"issue":"8","key":"294_CR3","first-page":"646","volume":"8","author":"E Carlsson","year":"2021","unstructured":"Carlsson E, Beresford MW, Ramanan AV, Dick AD, Hedrich CM (2021) Juvenile idiopathic arthritis associated uveitis. Children (Basel, Switzerland) 8(8):646","journal-title":"Children (Basel, Switzerland)"},{"issue":"7","key":"294_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11926-013-0341-3","volume":"15","author":"NV Palejwala","year":"2013","unstructured":"Palejwala NV, Yeh S, Angeles-Han ST (2013) Current perspectives on ophthalmic manifestations of childhood rheumatic diseases. Curr Rheumatol Rep 15(7):341","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"294_CR5","first-page":"786","volume":"95","author":"JP Spencer","year":"2017","unstructured":"Spencer JP, Trondsen Pawlowski RH, Thomas S (2017) Vaccine adverse events: separating myth from reality. Am Fam Physician 95(12):786\u2013794","journal-title":"Am Fam Physician"},{"issue":"10","key":"294_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","volume":"139","author":"F Pichi","year":"2021","unstructured":"Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG (2021) Association of Ocular Adverse Events with Inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol 139(10):1131\u20131135","journal-title":"JAMA Ophthalmol"},{"key":"294_CR7","doi-asserted-by":"crossref","unstructured":"Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, Zierhut M, Chee SP, Gupta V, Pavesio CE, de Smet\u00a0 MD, Agrawal R (2021) Ocular adverse events after COVID-19 vaccination.\u00a0Ocul Immunol Inflamm\u00a029(6):1216\u20131224","DOI":"10.1080\/09273948.2021.1976221"},{"issue":"6","key":"294_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","volume":"21","author":"Y Qian","year":"2010","unstructured":"Qian Y, Acharya NR (2010) Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 21(6):468\u2013472","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"294_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143(5):840\u2013846","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"294_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","volume":"12","author":"K Sabri","year":"2008","unstructured":"Sabri K, Saurenmann RK, Silverman ED, Levin AV (2008) Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 12(6):539\u2013545","journal-title":"J AAPOS"},{"key":"294_CR11","doi-asserted-by":"publisher","unstructured":"Tripathy K, Ying H, Maldonado Cerda A, Filipowicz A, Kaya M, Seymen Z, Anesi SD, Chang PY, Foster CS (2020) Widefield fundus fluorescein angiography features of uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm:1\u201310. Advance online publication. https:\/\/doi.org\/10.1080\/09273948.2020.1834586","DOI":"10.1080\/09273948.2020.1834586"},{"key":"294_CR12","doi-asserted-by":"publisher","unstructured":"Angeles-Han ST, Yeh S, Vogler LB (2013) Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis. Int J Clin Rheumatol 8(1). https:\/\/doi.org\/10.2217\/ijr.12.83","DOI":"10.2217\/ijr.12.83"},{"issue":"9","key":"294_CR13","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00417-016-3340-z","volume":"254","author":"M Oray","year":"2016","unstructured":"Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS (2016) Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study. Graefes Arch Clin Exp Ophthalmol 254(9):1841\u20131849","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"294_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3899\/jrheum.170710","volume":"45","author":"S Subesinghe","year":"2018","unstructured":"Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB (2018) A systematic review and Metaanalysis of Antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis. J Rheumatol 45(6):733\u2013744. https:\/\/doi.org\/10.3899\/jrheum.170710","journal-title":"J Rheumatol"},{"issue":"2","key":"294_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/annrheumdis-2018-214025","volume":"78","author":"JK Park","year":"2019","unstructured":"Park JK, Lee YJ, Bitoun S, Winthrop KL, Choi Y, Lee EB, Mariette X (2019) Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 78(2):282\u2013284","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"294_CR16","first-page":"898","volume":"77","author":"JK Park","year":"2018","unstructured":"Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB (2018) Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 77(6):898\u2013904","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"294_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/annrheumdis-2019-215187","volume":"78","author":"JK Park","year":"2019","unstructured":"Park JK, Choi Y, Winthrop KL, Song YW, Lee EB (2019) Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial. Ann Rheum Dis 78(9):1283\u20131284","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"294_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","volume":"27","author":"ET Cunningham Jr","year":"2019","unstructured":"Cunningham ET Jr, Moorthy RS, Fraunfelder FW, Zierhut M (2019) Vaccine-Associated Uveitis. Ocul Immunol Inflamm 27(4):517\u2013520","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"294_CR19","first-page":"48","volume":"113","author":"M Benage","year":"2016","unstructured":"Benage M, Fraunfelder FW (2016) Vaccine-Associated Uveitis. Mo Med 113(1):48\u201352","journal-title":"Mo Med"},{"issue":"6","key":"294_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/09273948.2016.1253983","volume":"24","author":"ET Cunningham Jr","year":"2016","unstructured":"Cunningham ET Jr, Forrester JV, Rao NA, Zierhut M (2016) Post-infectious Uveitis. Ocul Immunol Inflamm 24(6):603\u2013606","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"294_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0961203316686406","volume":"26","author":"A Watad","year":"2017","unstructured":"Watad A, Quaresma M, Brown S, Cohen Tervaert JW, Rodr\u00edguez-Pint I, Cervera R, Perricone C, Shoenfeld Y (2017) Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - an update. Lupus 26(7):675\u2013681","journal-title":"Lupus"},{"issue":"12","key":"294_CR22","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.autrev.2018.07.003","volume":"17","author":"TJ Cohen","year":"2018","unstructured":"Cohen TJ, W. (2018) Autoinflammatory\/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld's syndrome): a new flame. Autoimmun Rev 17(12):1259\u20131264","journal-title":"Autoimmun Rev"},{"issue":"1","key":"294_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","volume":"12","author":"I Testi","year":"2022","unstructured":"Testi I, Brand\u00e3o-de-Resende C, Agrawal R (2022) Pavesio C; COVID-19 Vaccination Ocular Inflammatory Events Study Group. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect 12(1):4. https:\/\/doi.org\/10.1186\/s12348-021-00275-x PMID: 34982290; PMCID: PMC8725430","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"10","key":"294_CR24","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.4103\/ijo.IJO_1435_21","volume":"69","author":"A Jain","year":"2021","unstructured":"Jain A, Kalamkar C (2021) COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol 69(10):2899\u20132900","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"294_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/vaccines9060572","volume":"9","author":"M Psichogiou","year":"2021","unstructured":"Psichogiou M, Samarkos M, Mikos N, Hatzakis A (2021) Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines 9(6):572","journal-title":"Vaccines"},{"key":"294_CR26","doi-asserted-by":"publisher","unstructured":"Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R (2021) Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male. Eur J Ophthalmol:11206721211046485. https:\/\/doi.org\/10.1177\/11206721211046485 Advance online publication","DOI":"10.1177\/11206721211046485"},{"issue":"3","key":"294_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S van Assen","year":"2011","unstructured":"van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, M\u00fcller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70(3):414\u2013422","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"294_CR28","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","volume":"38","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, Juvin R, Parchin-Geneste N, Piroth C, Wendling D, Kuntz JL, Tavernier C, Gaudin P (1999) Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 38(10):978\u2013983. https:\/\/doi.org\/10.1093\/rheumatology\/38.10.978","journal-title":"Rheumatology (Oxford)"},{"key":"294_CR29","doi-asserted-by":"publisher","unstructured":"ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM (2021) Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm:1\u20133. https:\/\/doi.org\/10.1080\/09273948.2021.1962917 Advance online publication","DOI":"10.1080\/09273948.2021.1962917"},{"issue":"1","key":"294_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","volume":"11","author":"I Papasavvas","year":"2021","unstructured":"Papasavvas I, Herbort CP Jr (2021) Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6\u2009years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflammation Infect 11(1):21","journal-title":"J Ophthalmic Inflammation Infect"},{"issue":"7","key":"294_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bjophthalmol-2021-319338","volume":"105","author":"M Phylactou","year":"2021","unstructured":"Phylactou M, Li JO, Larkin D (2021) Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol 105(7):893\u2013896","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"294_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40123-021-00338-1","volume":"10","author":"C Chau","year":"2021","unstructured":"Chau C, Chow L, Sridhar S, Shih KC (2021) Ophthalmological considerations for COVID-19 vaccination in patients with inflammatory eye diseases and autoimmune disorders. Ophthalmol Therapy 10(2):201\u2013209. https:\/\/doi.org\/10.1007\/s40123-021-00338-1","journal-title":"Ophthalmol Therapy"},{"key":"294_CR33","doi-asserted-by":"publisher","unstructured":"Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia-Dai V, Shulman S, Newman H, Biadsy M, Masarwa D, Fischer N, Yovel O, Ben Zaken SG, Habot-Wilner Z (2021) Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000003277 Advance online publication","DOI":"10.1097\/IAE.0000000000003277"},{"issue":"2","key":"294_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/vaccines10020342","volume":"10","author":"AA Haseeb","year":"2022","unstructured":"Haseeb AA, Solyman O, Abushanab MM, Abo Obaia AS, Elhusseiny AM (2022) Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccines (Basel) 10(2):342. https:\/\/doi.org\/10.3390\/vaccines10020342 PMID: 35214800; PMCID: PMC8875181","journal-title":"Vaccines (Basel)"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-022-00294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-022-00294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-022-00294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T09:03:29Z","timestamp":1651050209000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-022-00294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s12348-022-00294-2","relation":{},"ISSN":["1869-5760"],"issn-type":[{"type":"electronic","value":"1869-5760"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital ethics committee (Narayana Nethralaya Ethics committee). All tenets of the Helsinki declaration were adhered to.Patient\u2019s written and informed consent was obtained for inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient\u2019s written and informed consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}